On-Demand Webinar: Label-Free AI-Driven Analysis of Chemotherapeutic Cytotoxicity in Glia
Duration: 23 minutes
The response of tumor cells, such as glioblastomas, to cytotoxic chemotherapeutic compounds is a complex and dynamic process that is crucial to understand in neuro-oncology research.
In this webinar we will explore the benefits of integrating AI into live-cell image analysis workflows and discuss the new Incucyte® AI Cell Health Analysis software module. The integrated software is powered by pre-trained neural networks and is a robust solution for label-free segmentation and Live/Dead classification of individual cells.
We will further examine how this AI-driven approach can be utilized to assess cytotoxicity in glial cells and is amenable to the screening of therapeutic candidates.
Join us to:
- Learn about the benefits of AI-driven analysis
- Gain an overview of label-free cytotoxicity assays
- Explore case study data that supports the use of label-free assays within the field of neuro-oncology
This webinar will benefit:
- Scientists performing cytotoxicity or compound screening assays
- Individuals who desire to implement live-cell imaging into their workflow
- Researchers involved in fundamental research and therapeutic development within the fields of oncology and neuroscience
Webinar Speaker
Jasmine Trigg
Scientist
Sartorius
Jasmine is a Scientist at Sartorius as part of the BioAnalytics group. Over the past couple of years, she has worked across multiple research areas developing cellular assays and analytical tools to extend the suite of Incucyte® live-cell analysis applications. Jasmine has a background in Neuroscience and Genetic Manipulation and her earlier work focused on using a combined structural and molecular biology approach to assess disease-associated proteins implicated in Alzheimer’s disease
